News Selexis and NexImmune Sign Service Agreement to Advance Multiple Immunotherapies Targeting Rare Cancers and Autoimmune Disorders Agreement supports the development of molecules targeting acute myeloid leukemia, multiple myeloma, human papilloma virus…Super UserSeptember 12, 2022
News Johns Hopkins Technology Ventures | View Our FY22 Annual Report I'm pleased to share with you JHTV's annual report for Fiscal Year 2022. As we…Super UserSeptember 12, 2022
News MIMETAS appoints Dhaval Patel as Chair of the Board of Directors LEIDEN, September 8, 2022 - MIMETAS, a global leader in organ-on-chip-based disease models for drug…Super UserSeptember 12, 2022
News Jeeva is ranked among 61 Most Promising Clinical Trials Startups with Seed Funding (United States) Just Funded selected the organizations listed in this article based on: Track record Executive leadership…Super UserSeptember 12, 2022
News Rockville biotech Shuttle Pharmaceuticals shares climb 373% on first day of trading – Rockville Economic Development, Inc On its first day as a publicly traded company Wednesday, Rockville-based Shuttle Pharmaceuticals Holdings Inc.…Super UserSeptember 7, 2022
News Kurt Newman to retire as Children’s National Hospital CEO – Washington Business Journal The first time Kurt Newman walked into the Children’s National Hospital atrium as a thirtysomething…Super UserSeptember 6, 2022
News Equity Incubator at the Universities at Shady Grove – Fall 2022 Application Thank you for your interest in joining the Entrepreneurship Lab Equity Incubator at the Universities…Super UserSeptember 6, 2022
News Emergent BioSolutions Initiates Phase 1 Study Evaluating Lassa Virus Vaccine Candidate GAITHERSBURG, Md., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced…Super UserSeptember 6, 2022
News QIAGEN announces winners of 2022 Young Investigator Awards The competition nurtures young scientists around the globe QIAGEN-Verogen generously donated a combined instrument and…Super UserSeptember 6, 2022
News Ampel BioSolutions Enters MDx Market With Lupus, Dermatology Gene Expression Assays | Genomeweb – 2 GENOME WEB, CHICAGO, IL, September 1, 2022 - - After nine years in business, precision…Super UserSeptember 6, 2022